• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

简短报告:奥美拉唑联合抗生素治疗幽门螺杆菌相关性十二指肠溃疡

Short report: treatment of Helicobacter pylori-associated duodenal ulcer with omeprazole plus antibiotics.

作者信息

McCarthy C J, Collins R, Beattie S, Hamilton H, O'Morain C

机构信息

Department of Gastroenterology, Meath/Adelaide Hospitals, Trinity College, Dublin, Ireland.

出版信息

Aliment Pharmacol Ther. 1993 Aug;7(4):463-6. doi: 10.1111/j.1365-2036.1993.tb00121.x.

DOI:10.1111/j.1365-2036.1993.tb00121.x
PMID:8218761
Abstract

Omeprazole heals most duodenal ulcers after 4 weeks of treatment but relapse is common. Eradication of Helicobacter pylori is associated with reduced rate of ulcer relapse. This study investigates the effect of omeprazole with antibiotics in H. pylori-associated duodenal ulceration. Forty-three patients with endoscopically proven duodenal ulcer and H. pylori entered this study. Treatment consisted of 20 mg omeprazole daily (four weeks) and seven days (first week) treatment with 400 mg metronidazole t.d.s. and 500 mg tetracycline t.d.s. Four weeks after completing the treatment, 81% (35/43) had a healed duodenal ulcer, and 58% (25/43) had H. pylori eradication. In those who healed, at one year 21 remained H. pylori-negative, 12 had persistent H. pylori infection and 2 had re-infection. The ulcer relapse rate at one year was 26%: of the 9 who relapsed, 6 had persistent infection, 2 were re-infected, and only 1 was H. pylori-negative. This combination therapy of antibiotics with omeprazole successfully eradicates Helicobacter pylori and has a lower ulcer relapse than omeprazole alone.

摘要

奥美拉唑治疗4周后可治愈大多数十二指肠溃疡,但复发很常见。根除幽门螺杆菌可降低溃疡复发率。本研究调查了奥美拉唑联合抗生素治疗幽门螺杆菌相关性十二指肠溃疡的效果。43例经内镜证实患有十二指肠溃疡且感染幽门螺杆菌的患者进入本研究。治疗方案为每日服用20毫克奥美拉唑(共四周),并在第一周同时服用甲硝唑400毫克,每日三次,四环素500毫克,每日三次,共七天。治疗结束四周后,81%(35/43)的患者十二指肠溃疡愈合,58%(25/43)的患者幽门螺杆菌被根除。在溃疡愈合的患者中,一年后21人幽门螺杆菌呈阴性,12人持续感染幽门螺杆菌,2人再次感染。一年时溃疡复发率为26%:在9例复发患者中,6例持续感染,2例再次感染,只有1例幽门螺杆菌呈阴性。抗生素与奥美拉唑的这种联合疗法成功根除了幽门螺杆菌,且溃疡复发率低于单用奥美拉唑。

相似文献

1
Short report: treatment of Helicobacter pylori-associated duodenal ulcer with omeprazole plus antibiotics.简短报告:奥美拉唑联合抗生素治疗幽门螺杆菌相关性十二指肠溃疡
Aliment Pharmacol Ther. 1993 Aug;7(4):463-6. doi: 10.1111/j.1365-2036.1993.tb00121.x.
2
Effect of triple therapy or amoxycillin plus omeprazole or amoxycillin plus tinidazole plus omeprazole on duodenal ulcer healing, eradication of Helicobacter pylori, and prevention of ulcer relapse over a 1-year follow-up period: a prospective, randomized, controlled study.三联疗法或阿莫西林加奥美拉唑或阿莫西林加替硝唑加奥美拉唑对十二指肠溃疡愈合、幽门螺杆菌根除及1年随访期内溃疡复发预防的影响:一项前瞻性、随机、对照研究。
Am J Gastroenterol. 1995 Sep;90(9):1419-23.
3
Efficacy of omeprazole combined with antibiotics for Helicobacter pylori eradication and duodenal ulcer recurrence.奥美拉唑联合抗生素根除幽门螺杆菌及预防十二指肠溃疡复发的疗效
Eur J Gastroenterol Hepatol. 1995 Feb;7(2):117-9.
4
One-week therapy with omeprazole, clarithromycin and metronidazole or ornidazole, followed by 3 weeks' treatment with omeprazole, eradicates Helicobacter pylori equally and heals duodenal ulcer.使用奥美拉唑、克拉霉素和甲硝唑或奥硝唑进行为期一周的治疗,随后使用奥美拉唑进行3周治疗,根除幽门螺杆菌的效果相同,且能治愈十二指肠溃疡。
Eur J Gastroenterol Hepatol. 1997 Dec;9(12):1185-9.
5
Effect of omeprazole and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the healing of duodenal ulcer: comparison with a historical control.奥美拉唑、阿莫西林联合甲硝唑对幽门螺杆菌根除及十二指肠溃疡愈合的影响:与历史对照比较
Hepatogastroenterology. 1999 Jul-Aug;46(28):2358-62.
6
Efficacy and Tolerability of Two Quadruple Regimens: Bismuth, Omeprazole, Metronidazole with Amoxicillin or Tetracycline as First-Line Treatment for Eradication of Helicobacter Pylori in Patients with Duodenal Ulcer: A Randomized Clinical Trial.铋剂四联疗法(含阿莫西林或四环素)与奥美拉唑、甲硝唑三联疗法作为一线治疗方案根除十二指肠溃疡患者幽门螺杆菌的疗效和耐受性:一项随机临床试验。
PLoS One. 2018 Jun 11;13(6):e0197096. doi: 10.1371/journal.pone.0197096. eCollection 2018.
7
Triple therapy with sucralfate, tetracycline, and metronidazole for Helicobacter pylori-associated duodenal ulcers.硫糖铝、四环素和甲硝唑三联疗法治疗幽门螺杆菌相关性十二指肠溃疡。
Am J Gastroenterol. 1995 Sep;90(9):1424-7.
8
Omeprazole/amoxicillin versus triple therapy for Helicobacter pylori in duodenal ulcer disease: two-year follow-up of a prospective randomized study.奥美拉唑/阿莫西林与三联疗法治疗十二指肠溃疡疾病中的幽门螺杆菌:一项前瞻性随机研究的两年随访
Z Gastroenterol. 1995 Oct;33(10):590-3.
9
Triple therapy eradicated H. pylori equally in patients pretreated with omeprazole or ranitidine. A 12-month follow-up.三联疗法在接受过奥美拉唑或雷尼替丁预处理的患者中根除幽门螺杆菌的效果相同。进行了为期12个月的随访。
J Clin Gastroenterol. 1995 Jan;20(1):12-6. doi: 10.1097/00004836-199501000-00005.
10
Symptomatic and endoscopic duodenal ulcer relapse rates 12 months following Helicobacter pylori eradication treatment with omeprazole and amoxycillin with or without metronidazole.采用奥美拉唑和阿莫西林联合或不联合甲硝唑进行幽门螺杆菌根除治疗12个月后的症状性和内镜下十二指肠溃疡复发率。
Aliment Pharmacol Ther. 1996 Aug;10(4):637-44. doi: 10.1046/j.1365-2036.1996.36178000.x.

引用本文的文献

1
Does seropositivity for Helicobacter pylori antibodies increase outpatient costs for gastric and duodenal ulcer or inflammation?幽门螺杆菌抗体血清阳性会增加胃和十二指肠溃疡或炎症的门诊费用吗?
Pharmacoeconomics. 2004;22(15):975-83. doi: 10.2165/00019053-200422150-00002.
2
Recurrence of Helicobacter pylori infection after successful eradication: nature and possible causes.幽门螺杆菌成功根除后的复发:本质及可能原因
Dig Dis Sci. 1997 Sep;42(9):1821-34. doi: 10.1023/a:1018827322470.
3
Gastroenterology--I: Gastroduodenal disease and Helicobacter pylori.
胃肠病学——I:胃十二指肠疾病与幽门螺杆菌
Postgrad Med J. 1994 Aug;70(826):561-7. doi: 10.1136/pgmj.70.826.561.
4
Effect of Helicobacter pylori eradication on peptic ulcer healing.幽门螺杆菌根除对消化性溃疡愈合的影响。
Postgrad Med J. 1995 Feb;71(832):90-3. doi: 10.1136/pgmj.71.832.90.
5
Omeprazole enhances efficacy of triple therapy in eradicating Helicobacter pylori.奥美拉唑可提高三联疗法根除幽门螺杆菌的疗效。
Gut. 1995 Oct;37(4):477-81. doi: 10.1136/gut.37.4.477.